AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Active Biotech

Declaration of Voting Results & Voting Rights Announcements Nov 8, 2022

3133_iss_2022-11-08_979da0e7-8096-4705-a348-74df110d8e12.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

Issuer Active Biotech AB (publ)

Holder

Sjuenda Holding AB

Instrument

Instrument Aktie SE0001137985
Before the transaction
Shares 11,758,290
Voting rights 11,758,290
Transaction
Date 04/11/2022
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 14,661,769
Directly held voting rights 14,661,769
Indirectly held voting rights 0

Percentage

Directly held shares 5.54 % Directly held voting rights 5.54 % Indirectly held voting rights 0 %

Resulting distribution of total holdings

Shares Percentage of voting
rights:
Number of underlying
shares:
5.54 % 14,661,769
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.54 % 14,661,769

Notes (other relevant informations according to law)

  1. Basen 264 886 797 utestående aktier är den nya bas som uppstod vid nyemissionen i september 2022. 2. Förvärvet av aktier sker från Peter Thelin, som är helägare till Sjuenda Holding AB. Förvärvet förändrar således inte Peter Thelins sammanlagda direkta och indirekta innehav i Active Biotech, som alltjämt uppgår till tidigare flaggade 5,8. Genom förvärvet äger emellertid Sjuenda Holding AB aktier överskridande flaggningsgränsen om 5 procent (tidigare 4,4 procent).

Published

08/11/2022 14:50

Contact

Name Joakim Schaaf Phone +46761111483 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.